Covered recipient · General Payments record
CATHY-ANNE MARIA CHARLES
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$1,231.36
- Reported across 44 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $344.73 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Abbott Laboratories | $140.77 | 1 |
| ABBVIE INC. | $78.21 | 4 |
| SHIELD THERAPEUTICS INC | $45.67 | 2 |
| Avvisto Therapeutics, LLC | $22.34 | 1 |
| Daiichi Sankyo Inc. | $22.29 | 1 |
| Novo Nordisk AS | $18.85 | 1 |
| Acerta Pharma LLC | $16.60 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $140.77 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125273180 | CMS |
| ABBVIE INC. | $26.19 | 01/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103445800 | CMS |
| ABBVIE INC. | $17.08 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103445802 | CMS |
| ABBVIE INC. | $21.22 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103445804 | CMS |
| ABBVIE INC. | $13.72 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103445806 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.60 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104457430 | CMS |
| Avvisto Therapeutics, LLC | $22.34 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119887952 | CMS |
| Daiichi Sankyo Inc. | $22.29 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089407768 | CMS |
| Novo Nordisk Inc | $18.85 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097258257 | CMS |
| SHIELD THERAPEUTICS INC | $22.82 | 07/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150137743 | CMS |
| SHIELD THERAPEUTICS INC | $22.85 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150143534 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.